Involvement of the JAK-STAT Pathway and SOCS3 in the regulation of adiponectin-generated reactive oxygen species in murine macrophage raw 264 cells

Journal of Cellular Biochemistry

Volumn 111, Issue 3, 2010, Pages 597-606

  Akifusa, Sumio ^a   Kamio, Noriaki ^a   Shimazaki, Yoshihiro ^a   Yamaguchi, Noboru ^a   Nonaka, Kazuaki ^a   Yamashita, Yoshihisa ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Adiponectin; Macrophage; Nitric Oxide; Reactive Oxygen Species; Suppressor Of Cytokine Signaling 3

Indexed keywords

ADIPONECTIN; CASPASE; CYTOKINE; JANUS KINASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SPECIES; STATISTICAL SIGNIFICANCE; STIMULATION; TRANSDUCER; VECTOR CONTROL; WESTERN BLOTTING;

ADIPONECTIN; ANIMALS; APOPTOSIS; CELL LINE; JANUS KINASES; MACROPHAGES; MICE; NITRIC OXIDE; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

MURINAE;

EID: 78651283555     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22745     Document Type: Article

References (44)

1. Abe J, Berk BC. 1999. Fyn and JAK2 mediate Ras activation by reactive oxygen species. J Biol Chem 274:21003-21010.
2. Akifusa S, Kamio N, Shimazaki Y, Yamaguchi N, Yamashita Y. 2008. Regulation of globular adiponectin-induced apoptosis by reactive oxygen/nitrogen species in RAW264 macrophages. Free Radic Biol Med 45:1326-1339.
3. Akifusa S, Kamio N, Shimazaki Y, Yamaguchi N, Nishihara T, Yamashita Y. 2009. Globular adiponectin-induced RAW 264 apoptosis is regulated by a reactive oxygen species-dependent pathway involving Bcl-2. Free Radic Biol Med 46:1308-1316.
4. Berg AH, Combs TP, Scherer PE. 2002. ACRP30/adiponectin: An adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13:84-89.
5. Caceres-Cortes JR. 2008. A potent anti-carcinoma and anti-acute myeloblastic leukemia agent, AG490. Anticancer Agents Med Chem 8:717-722.
6. Coope A, Milanski M, Araujo EP, Tambascia M, Saad MJ, Geloneze B, Velloso LA. 2008. AdipoR1 mediates the anorexigenic and insulin/leptin-like actions of adiponectin in the hypothalamus. FEBS Lett 582:1471-1476.
7. Croker BA, Metcalf D, Robb L, Wei W, Mifsud S, DiRago L, Cluse LA, Sutherland KD, Hartley L, Williams E, Zhang JG, Hilton DJ, Nicola NA, Alexander WS, Roberts AW. 2004. SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity 20:153-165.
8. Dalpke AH, Opper S, Zimmermann S, Heeg K. 2001. Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs. J Immunol 166:7082-7089.
9. Dalpke A, Heeg K, Bartz H, Baetz A. 2008. Regulation of innate immunity by suppressor of cytokine signaling (SOCS) proteins. Immunobiology 213:225-235.
10. Deepa SS, Dong LQ. 2009. APPL1: Role in adiponectin signaling and beyond. Am J Physiol Endocrinol Metab 296:E22-E36.
11. Egwuagu CE, Yu CR, Zhang M, Mahdi RM, Kim SJ, Gery I. 2002. Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: Implications for Th cell lineage commitment and maintenance. J Immunol 168:3181-3187.
12. Emanuelli B, Glondu M, Filloux C, Peraldi P, Van Obberghen E. 2004. The potential role of SOCS-3 in the interleukin-1beta-induced desensitization of insulin signaling in pancreatic beta-cells. Diabetes 53(Suppl 3): S97-S103.
13. Folco EJ, Rocha VZ, Lopez-Ilasaca M, Libby P. 2009. Adiponectin inhibits pro-inflammatory signaling in human macrophages independently of interleukin- 10. J Biol Chem.
14. Ghigo D, Riganti C, Gazzano E, Costamagna C, Bosia A. 2006. Cycling of NADPH by glucose 6-phosphate dehydrogenase optimizes the spectrophotometric assay of nitric oxide synthase activity in cell lysates. Nitric Oxide 15:148-153.
15. Gokulakrishnan K, Mohanavalli KT, Monickaraj F, Mohan V, Balasubramanyam M. 2009. Subclinical inflammation/oxidation as revealed by altered gene expression profiles in subjects with impaired glucose tolerance and Type 2 diabetes patients. Mol Cell Biochem 324:173-181.
16. Heim MH. 1999. The Jak-STAT pathway: Cytokine signalling from the receptor to the nucleus. J Recept Signal Transduct Res 19:75-120.
17. Howard JK, Cave BJ, Oksanen LJ, Tzameli I, Bjorbaek C, Flier JS. 2004. Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Nat Med 10:734-738.
18. Huang H, Park PH, McMullen MR, Nagy LE. 2008. Mechanisms for the antiinflammatory effects of adiponectin in macrophages. J Gastroenterol Hepatol 23(Suppl 1): S50-S53.
19. Jo D, Liu D, Yao S, Collins RD, Hawiger J. 2005. Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis. Nat Med 11:892-898.
20. Kamio N, Akifusa S, Yamaguchi N, Yamashita Y. 2008. Induction of granulocyte colony-stimulating factor by globular adiponectin via the MEK-ERK pathway. Mol Cell Endocrinol 292:20-25.
21. Kamio N, Akifusa S, Yamaguchi N, Nonaka K, Yamashita Y. 2009. Antiinflammatory activity of a globular adiponectin function on RAW 264 cells stimulated by lipopolysaccharide from Aggregatibacter actinomycetemcomitans. FEMS Immunol Med Microbiol 56:241-247.
22. KarlsenAE,RonnSG, LindbergK, JohannesenJ,GalsgaardED,Pociot F, Nielsen JH, Mandrup-Poulsen T, Nerup J, Billestrup N. 2001. Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma-mediated toxicity. Proc Natl Acad Sci USA 98:12191-12196.
23. Le Y, Zhu BM, Harley B, Park SY, Kobayashi T, Manis JP, Luo HR, Yoshimura A, Hennighausen L, Silberstein LE. 2007. SOCS3 protein developmentally regulates the chemokine receptor CXCR4-FAK signaling pathway during B lymphopoiesis. Immunity 27:811-823.
24. Liao W, Yu C, Wen J, Jia W, Li G, Ke Y, Zhao S, Campell W. 2009. Adiponectin induces interleukin-6 production and activates STAT3 in adult mouse cardiac fibroblasts. Biol Cell 101:263-272.
25. Liu X, Mameza MG, Lee YS, Eseonu CI, Yu CR, Kang Derwent JJ, Egwuagu CE. 2008. Suppressors of cytokine-signaling proteins induce insulin resistance in the retina and promote survival of retinal cells. Diabetes 57:1651-1658.
26. Naka T, Matsumoto T, Narazaki M, Fujimoto M, Morita Y, Ohsawa Y, Saito H, Nagasawa T, Uchiyama Y, Kishimoto T. 1998. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc Natl Acad Sci USA 95:15577-15582.
27. Ouchi N, Walsh K. 2007. Adiponectin as an anti-inflammatory factor. Clin Chim Acta 380:24-30.
28. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, Engel J, Brownlee M, Scherer PE. 2003. Structure-function studies of the adipocytesecreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem 278:9073-9085.
29. Park PH, Huang H, McMullen MR, Mandal P, Sun L, Nagy LE. 2008. Suppression of lipopolysaccharide-stimulated tumor necrosis factor-alpha production by adiponectin is mediated by transcriptional and post-transcriptional mechanisms. J Biol Chem 283:26850-26858.
30. Park YC, Jun CD, Kang HS, Kim HD, Kim HM, Chung HT. 1996. Role of intracellular calcium as a priming signal for the induction of nitric oxide synthesis in murine peritoneal macrophages. Immunology 87:296-302.
31. Samardzija M, Wenzel A, Aufenberg S, Thiersch M, Reme C, Grimm C. 2006. Differential role of Jak-STAT signaling in retinal degenerations. FASEB J 20:2411-2413.
32. Sasaki A, Yasukawa H, Shouda T, Kitamura T, Dikic I, Yoshimura A. 2000. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2. J Biol Chem 275:29338-29347.
33. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. 1995. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270:26746-26749.
34. Waki H, Yamauchi T, Kamon J, Kita S, Ito Y, Hada Y, Uchida S, Tsuchida A, Takekawa S, Kadowaki T. 2005. Generation of globular fragment of adipo- nectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology 146:790-796.
35. Wang Y, Lam KS, Yau MH, Xu A. 2008. Post-translational modifications of adiponectin: Mechanisms and functional implications. Biochem J 409:623-633.
36. Wulster-Radcliffe MC, Ajuwon KM, Wang J, Christian JA, Spurlock ME. 2004. Adiponectin differentially regulates cytokines in porcine macrophages. Biochem Biophys Res Commun 316:924-929.
37. Yamaguchi N, Argueta JG, Masuhiro Y, Kagishita M, Nonaka K, Saito T, Hanazawa S, Yamashita Y. 2005. Adiponectin inhibits Toll-like receptor family-induced signaling. FEBS Lett 579:6821-6826.
38. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, MiyagishiM,HaraK, Tsunoda M,Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, TsunoNH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T. 2003. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762-769.
39. Yasukawa H, Misawa H, Sakamoto H, Masuhara M, Sasaki A, Wakioka T, Ohtsuka S, Imaizumi T, Matsuda T, Ihle JN, Yoshimura A. 1999. The JAKbinding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J 18:1309-1320.
40. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, Kihara S, Funahashi T, Tenner AJ, Tomiyama Y, Matsuzawa Y. 2000. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96:1723-1732.
41. Yu CR, Mahdi RM, Ebong S, Vistica BP, Chen J, Guo Y, Gery I, Egwuagu CE. 2004. Cell proliferation and STAT6 pathways are negatively regulated in T cells by STAT1 and suppressors of cytokine signaling. J Immunol 173:737-746.
42. Zacharioudaki V, Androulidaki A, Arranz A, Vrentzos G, Margioris AN, Tsatsanis C. 2009. Adiponectin promotes endotoxin tolerance in macrophages by inducing IRAK-M expression. J Immunol 182:6444-6451.
43. Zhong M, Henriksen MA, Takeuchi K, Schaefer O, Liu B, ten Hoeve J, Ren Z, Mao X, Chen X, Shuai K, Darnell JE, Jr., 2005. Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation-inactivation cycle. Proc Natl Acad Sci USA 102:3966-3971.
44. 2+/CaMKK-dependent pathways. J Biol Chem 284:22426-22435.